Nexrutine Manages Pain and Inflammation

According to a new open-label study, Next Pharmaceuticals’ patent-pending proprietary botanical ingredient, Nexrutine, has been shown to help manage pain and inflammation in as short as two weeks. This study sets Nexrutine apart from the many other anti-inflammatory dietary supplements by its ability to produce significant results in a short period of time. Participants of the study included 288 patients at the Living Longer Clinic, Cincinnati, OH. Nexrutine reduced pain and/or inflammation and increased mobility and flexibility in 88% of the subjects.

For further information: 818-755-8803.